Seaport Therapeutics, Inc. (SPTX)
27.84
+3.01
(+12.12%)
USD |
NASDAQ |
Aug 26, 16:00
27.86
+0.02
(+0.07%)
After-Hours: 07:48
Seaport Therapeutics Shareholders Equity (Quarterly) : 422.60M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 422.60M |
| Date | Value |
|---|---|
| March 31, 2026 | 209.71M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Johnson & Johnson | 84.97B |
| Bristol Myers Squibb Co. | 22.32B |
| Pfizer Inc. | 85.19B |
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 441.68M |
| Total Liabilities (Quarterly) | 19.08M |
| Debt to Equity Ratio | 0.0119 |
| Current Ratio | 18.00 |
| Net Debt Paydown Yield | -0.07% |